The CooperCOO +4.04%85 Gross Margin % is 68.00% as of Apr. 2026, which is 4% above its 10-year median of 65.11. GuruFocus rates COO with a GF Score™ of 85/100 and a GF Value™ of $100.85 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 805 Medical Devices & Instruments companies, The Cooper ranks better than 71.93% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. The Cooper's Gross Profit for the
three
months ended in Apr. 2026 was $735 Mil. The Cooper's Revenue for the
three
months ended in Apr. 2026 was $1,082 Mil. Therefore, The Cooper's Gross Margin % for the quarter that ended in Apr. 2026 was 68.00%.
The historical rank and industry rank for The Cooper's Gross Margin % or its related term are showing as below:
COO'
s Gross Margin % Range Over the Past 10 Years
Min: 59.65 Med: 65.11 Max: 66.92
Current: 65.55
During the past 13 years, the highestGross Margin % of The Cooper was 66.92%. The lowest was 59.65%. And the median was 65.11%.
COO's Gross Margin % is ranked better than 71.93% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs COO: 65.55
The Cooper had a gross margin of 68.00% for the quarter that ended in Apr. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for The Cooper was 0.50% per year.
The Cooper (NAS:COO) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
The Cooper had a gross margin of 68.00% for the quarter that ended in Apr. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
The Cooper Gross Margin % Related Terms
The Cooper Gross Margin % Historical Data
* Premium members only.
The historical data trend for The Cooper's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, The Cooper's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Gross Margin % distribution charts can be found below:
* The bar in red indicates where The Cooper's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
The Cooper (COO) has a Gross Margin % of 68.00% as of Apr. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on The Cooper and its competitors. This is near median its historical median of 65.11. Over the past decade, The Cooper's Gross Margin % has ranged from 59.65 to 66.92. According to the industry distribution chart, The Cooper ranks #226 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 28.1%.
Is The Cooper's Gross Margin % too high?
The Cooper's current Gross Margin % of 68.00% is near median its 10-year median of 65.11. Over the past 10 years, this metric has ranged from a low of 59.65 to a high of 66.92. The Medical Devices & Instruments industry median Gross Margin % is 52.07. The Cooper's value of 68.00% is 30.6% above this industry median. Based on the distribution chart, The Cooper ranks #226 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, The Cooper has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's Gross Margin % compare to ALGN and SOLV?
According to the Medical Devices & Instruments industry distribution chart, The Cooper ranks #226 out of 805 companies for Gross Margin %. This puts The Cooper in the upper half of its industry. The industry median Gross Margin % is 52.07. The Cooper's value of 68.00% is 30.6% above this benchmark. Historically, The Cooper's own Gross Margin % has ranged from 59.65 to 66.92 over the past decade. While the company's 10-year median is 65.11 vs. the industry median of 52.07, The Cooper has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Cooper's current Gross Margin % of 68.00% is 30.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on The Cooper and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Cooper's current Gross Margin % is 68.00%, which is near median its own 10-year median of 65.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (COO) is currently considered Significantly Undervalued. The stock's GF Value™ is $100.85, compared to a current price of $68.83 — trading 31.8% below its estimated fair value. The current Gross Margin % is 68.00%, which is near median its 10-year median of 65.11 and 30.6% above the Medical Devices & Instruments industry median of 52.07. The Cooper's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For The Cooper (COO), the current Gross Margin % is 68.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cooper (COO) Overvalued in 2026?
Based on GuruFocus' analysis, The Cooper stock appears to be undervalued.
The current stock price of $68.83 is trading 31.8% below its estimated GF Value™ of $100.85.
GuruFocus considers The Cooper to be Significantly Undervalued.
Key valuation signals for COO:
Gross Margin %: 68.00% (near median its 10-year median of 65.11)
GF Value™: $100.85 vs. price of $68.83 (31.8% below fair value)
Industry Position: 30.6% above the Medical Devices & Instruments median (#226 of 805)
No single metric tells the full story. See the COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
85GF Score
Get the complete analysis for COO
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COO has been successfully added to your 
